Table 2.
OLZ-10-N-glucuronide isomer 1 | OLZ-10-N-glucuronide isomer 2 | OLZ-4’-N-glucuronide | |||||||
---|---|---|---|---|---|---|---|---|---|
HLM genotype |
Vmax (pmol·min−1·mg−1) |
KM (µM) |
Vmax/KM (µl·min−1·mg−1) |
Vmax (pmol·min−1·mg−1) |
KM (µM) |
Vmax/KM (µl·min−1·mg−1) |
Vmax (pmol·min−1·mg−1) |
KM (µM) |
Vmax/KM (µl·min−1·mg−1) |
UGT1A4(*1/*1)/ UGT2B10(*1/*1)* |
94.0 ± 14 | 352 ± 59 | 0.28 ± 0.08 | 63 ± 23 | 311 ± 27 | 0.2 ± 0.07 | 82 ± 20 | 317 ± 39 | 0.26 ± 0.07 |
UGT1A4(*1/*3)/ UGT2B10(*1/*1)* |
160 ± 14a | 328 ± 33 | 0.50 ± 0.08b | 73 ± 17 | 239 ± 22b | 0.31 ± 0.08 | 70 ± 24d | 263 ± 59 | 0.26 ± 0.04e |
UGT1A4(*3/*3)/ UGT2B10(*1/*1)* |
188 ± 47b | 268 ± 41 | 0.70 ± 0.07c | 106 ± 16 | 263 ± 86 | 0.42 ± 0.08 | 156 ± 18b | 337 ± 37 | 0.46 ± 0.01c |
UGT2B10(*1/*2)/ UGT1A4(*1/*1)** |
56 ± 23d | 302 ± 50 | 0.19 ± 0.08f | 30 ± 14e | 196 ± 54b | 0.16 ± 0.09 | 47 ± 20e | 602 ± 57a,e | 0.08 ± 0.03b,g |
UGT2B10(*2/*2)/ UGT1A4(*1/*1)** |
69 | 273 | 0.25 | 41.5 | 271 | 0.15 | 37 | 796 | 0.047 |
Three HLM with the UGT1A4 (*1/*1) genotype, three HLM with the UGT1A4 (*1/*3) genotype, and two HLM with the UGT1A4 (*3/*3) genotype were examined in this analysis. Only HLM with the UGT2B10 (*1/*1) genotype was used to compare varying UGT1A4 genotypes. HLMs of each genotype were chosen at random.
Three HLM with the UGT2B10 (*1/*2) genotype and the single HLM with the UGT2B10 (*2/*2) genotype were examined in this analysis. Only HLM with the UGT1A4 (*1/*1) genotype were used to compare varying UGT2B10 genotypes.
p<0.005
p<0.05
p<0.01 versus the corresponding value for HLM with the UGT1A4 (*1/*1)/UGT2B10 (*1/*1) genotype.
p<0.05
p<0.01
p<0.005
p<1 versus the corresponding value for HLM with the UGT1A4 (*3/*3)/UGT2B10 (*1/*1) genotype.